Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial Fibrillation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01716143
Recruitment Status : Unknown
Verified October 2012 by Youquan Wei, The First Affiliated Hospital with Nanjing Medical University. Recruitment status was: Recruiting
First Posted : October 29, 2012
Last Update Posted : October 29, 2012
The First Affiliated Hospital with Nanjing Medical University
Information provided by (Responsible Party):
Youquan Wei, The First Affiliated Hospital with Nanjing Medical University
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
All persistent or permanent AF patients with refractory or intolerant to at least one Class 1 or Class 3 antiarrhythmic medication.
Patients with paroxysmal AF (self-terminating episodes lasting < 7 day)
Patients who have had a previous AF ablation procedure